WSW, NY, 24th March 2026, FinanceWire … Read More
ETFs
Entera May Be the 1st Winner of FDA’s New Framework Redefining the Multi Billion Dollar Osteoporosis Market
WSW, NY, 23rd March 2026, FinanceWire … Read More
Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN)
WSW, NY, 20th March 2026, FinanceWire … Read More
Purple Biotech Is Building What Could Be the Next Generation of Cancer Immunotherapy (NASDAQ: PPBT)
WSW, NY, 20th March 2026, FinanceWire … Read More
Duke Robotics Lands $1M+ Contract as Trump’s $1.9B Initiative Creates Tailwind Drone Innovator (OTCQB: DUKRD)
WSW, NY, 19th March 2026, FinanceWire … Read More
Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)
WSW, NY, 19th March 2026, FinanceWire … Read More
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
WSW, NY, 18th March 2026, FinanceWire … Read More
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
WSW, NY, 16th March 2026, FinanceWire … Read More
Duke Robotics Could Be One of the Underdog Companies Emerging From Israel’s Drone Tech Boom (OTCQB: DUKRD)
WSW, NY, 12th March 2026, FinanceWire … Read More
Entera Takes Final Step Towards Phase 3, Accelerating Timeline for First Oral Anabolic Osteoporosis Therapy
WSW, NY, 12th March 2026, FinanceWire … Read More